An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the National Institutes of Health. The FLINT study found that people with nonalcoholic steatohepatitis (NASH) who took obeticholic acid (OCA) had improved liver health during that period, including decreased inflammation and fat in the liver and decreased body weight versus people receiving a placebo. OCA was also associated with increases in itching and total cholesterol.

Related posts:

  1. Study to test treatment for fatty liver disease in children With the launch of a new clinical trial supported by the National Institutes of Health, researchers are working to determine whether treating children diagnosed with the most severe form of fatty liver disease with a drug called cysteamine will help improve the liver....
  2. Medicare Card, Diet Supplement Recalled After Being Linked to Liver Failure and Death OxyElite Pro, a diet supplement marketed for weight loss and muscle growth, was recalled after being linked to acute liver failure and cases of hepatitis. The Food and Drug Administration (FDA) reports that the supplement caused one death and several patients required liver transplants. The FDA is advising people to immediately stop using OxyElite Pro and […]...
  3. Vitamin E helps diminish a type of fatty liver disease in children Vitamin E helps diminish a type of fatty liver disease in children...
  4. Medicare Card, Tip Two on How to Prevent High Blood Pressure Medicare Card, Tip Two on How to Prevent High Blood Pressure...
  5. Medicare Card, Common treatment for patients with chronic, progressive lung disease found to be ineffective Medicare Card, Common treatment for patients with chronic, progressive lung disease found to be ineffective...
  6. Medicare Card, NIH launches free database of drugs associated with liver injury Medicare Card, NIH launches free database of drugs associated with liver injury...
  7. Medicare Card, Cholesterol Screening Medicare Card, Cholesterol Screening...
  8. Medicare Card, Eating Disorders can be Deadly Medicare Card, Eating Disorders can be Deadly...
  9. Medicare Card, How to prevent or treat high cholesterol Medicare Card, How to prevent or treat high cholesterol...
  10. Medicare Card, What Is Cholesterol Medicare Card, What Is Cholesterol ...
  11. Medicare Card, NIH study finds extreme obesity may shorten life expectancy up to 14 years Adults with extreme obesity have increased risks of dying at a young age from cancer and many other causes including heart disease, stroke, diabetes, and kidney and liver diseases, according to results of an analysis of data pooled from 20 large studies of people from three countries. The study, led by researchers from the National […]...
  12. MedicarCard.com Update – NIH Study Offers Hope to Patients with Nonalcoholic Steatohepatitis A daily dose of a specific form of vitamin E significantly improved the liver disease, nonalcoholic steatohepatitis (NASH), according to a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health...
  13. Medicare Card What is Lupus? Medicare Card What is Lupus?...
  14. Medicare Card Coverage – Common Mechanisms of Drug Abuse and Obesity Some of the same brain mechanisms that fuel drug addiction in humans accompany the emergence of compulsive eating behaviors and the development of obesity in animals, according to research funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. ...
  15. Medicare Card, NIH-funded researchers extend liver preservation for transplantation Medicare Card, NIH-funded researchers extend liver preservation for transplantation...